Labshake search
Citations for Bio-Synthesis :
1 - 4 of 4 citations for SARS Coronavirus Spike Glycoprotein S1 Mosaic N Term E. coli since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2021Quote: ... A standard curve comprised of synthetic RNA containing the target sequence from SARS-CoV-2 isolate WA1 sequence (GenBank Accession Number MN985325.1) (Bio-Synthesis, Inc.; Lewisville, TX) was included on each PCR plate for absolute quantitation of SARS-CoV-2 copies in each sample ...
-
bioRxiv - Immunology 2021Quote: ... A standard curve comprised of synthetic RNA containing the target sequence from SARS-CoV-2 isolate WA1 sequence (GenBank Accession Number MN985325.1) (Bio-Synthesis, Inc.; Lewisville, TX) was included on each PCR plate for absolute quantitation of SARS-CoV-2 RNA copies in each sample ...
-
bioRxiv - Microbiology 2021Quote: Total SARS-CoV-2 E gene and subgenomic E gene target copy numbers were determined by real-time RT-PCR using previously described assays (24–25) and a synthetic RNA containing the subgenomic E RNA sequence (Bio-Synthesis, Inc., Lewisville, TX, USA). Extracted nucleic acid was tested in triplicate (5 μL extracted nucleic acid ...
-
bioRxiv - Pharmacology and Toxicology 2020Quote: ... with human 15 N-terminal ANXA1 residues plus a cysteine residue at 16 position (MAMVSEFLKQAWFIEC) and L-MC16 mutants were synthesized by Bio-Synthesis (Lewisville, TX). IsodTIT7 ...